Complete replication of hepatitis B virus and hepatitis C virus in a newly developed hepatoma cell line

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 13, 2014, Pages

  Yang, Darong ^a   Zuo, Chaohui ^b   Wang, Xiaohong ^a   Meng, Xianghe ^a   Xue, Binbin ^a   Liu, Nianli ^a   Yu, Rong ^a   Qin, Yuwen ^a   Gao, Yimin ^a   Wang, Qiuping ^a   Hu, Jun ^b   Wang, Ling ^c   Zhou, Zebin ^d   Liu, Bing ^d   Tan, Deming ^c   Guan, Yang ^d   Zhu, Haizhen ^a,b  

^a HUNAN UNIVERSITY   (China)

^b HUNAN CANCER HOSPITAL   (China)

^c CENTRAL SOUTH UNIVERSITY   (China)

^d HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

CccDNA; Cell culture model; Interferon; ISGs; Primary human hepatocytes

Indexed keywords

ALPHA INTERFERON; ANTIVIRUS AGENT; BETA INTERFERON; CD81 ANTIGEN; CLAUDIN 1; HEPATITIS B SURFACE ANTIGEN; LAMIVUDINE; OCCLUDIN; SCAVENGER RECEPTOR BI; VIRUS DNA; VIRUS PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; DNA REPLICATION; DRUG EFFECT; ELECTRON MICROSCOPY; ENDOPLASMIC RETICULUM; HEPATITIS B; HEPATITIS C; HEPATOMA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; INNATE IMMUNITY; MALE; MIXED INFECTION; MOUSE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; QUANTITATIVE ASSAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA REPLICATION; SOUTHERN BLOTTING; VIRUS DETECTION; VIRUS ENTRY; VIRUS INFECTION; VIRUS ISOLATION; VIRUS PARTICLE; VIRUS REPLICATION;

CCCDNA; CELL CULTURE MODEL; INTERFERON; ISGS; PRIMARY HUMAN HEPATOCYTES;

ANIMALS; ANTIVIRAL AGENTS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; COINFECTION; HEPACIVIRUS; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HUMANS; LIVER NEOPLASMS; MALE; MICE; MICE, INBRED NOD; VIRUS REPLICATION;

EID: 84897507853     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1320071111     Document Type: Article

References (33)

1. El-Serag HB; EI-Serag HB (2012) Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology 142(6):1264-1273, e1.
2. Tujios SR, Lee WM (2012)New advances in chronic hepatitis B. Curr Opin Gastroenterol 28(3):193-197.
3. Rice CM (2011)New insights into HCV replication: Potential antiviral targets. Top Antivir Med 19(3):117-120.
4. Guidotti LG, Chisari FV (2006) Immunobiology and pathogenesis of viral hepatitis. Annu Rev Pathol 1:23-61.
5. Sells MA, Chen ML, Acs G (1987) Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA. Procatl Acad Sci USA 84(4): 1005-1009.
6. Ochiya T, et al. (1989) An in vitro system for infection with hepatitis B virus that uses primary human fetal hepatocytes. Procatl Acad Sci USA 86(6):1875-1879.
7. Galle PR, et al. (1994) In vitro experimental infection of primary human hepatocytes with hepatitis B virus. Gastroenterology 106(3):664-673.
8. Sureau C, Romet-Lemonne JL, Mullins JI, EssexM (1986) Production of hepatitis B virus by a differentiated human hepatoma cell line after transfection with cloned circular HBV DNA. Cell 47(1):37-47.
9. Yan H, et al. (2012) Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus. Elife 1:e00049.
10. Hantz O, et al. (2009) Persistence of the hepatitis B virus covalently closed circular DNA in HepaRG human hepatocyte-like cells. J Gen Virol 90(Pt 1):127-135.
11. Lidenbach BD, et al. (2005) Complete replication of hepatitis C virus in cell culture. Science 309(5734):623-626.
12. Zhong J, et al. (2005) Robust hepatitis C virus infection in vitro. Procatl Acad Sci USA 102(26):9294-9299.
13. Wakita T, et al. (2005) Production of infectious hepatitis C virus in tissue culture from a cloned viral genome Nat Med 11(7):791-796.
14. Li YP, et al. (2012) Robust full-length hepatitis C virus genotype 2a and 2b infectious cultures using mutations identified by a systematic approach applicable to patient strains. Procatl Acad Sci USA 109(18):E1101-E1110.
15. Li YP, et al. (2012) Highly efficient full-length hepatitis C virus genotype 1 (strain TN) infectious culture system. Procatl Acad Sci USA 109(48):19757-19762.
16. Steinmann E, Pietschmann T (2013) Cell culture systems for hepatitis C virus. Curr Top Microbiol Immunol 369:17-48.
17. Sheahan T, Jones CT, Ploss A (2010) Advances and challenges in studying hepatitis C virus in its native environment. Expert Rev Gastroenterol Hepatol 4(5):541-550.
18. Belloni L, et al. (2012) IFN-α inhibits HBV transcription and replication in cell culture and in humanized mice by targeting the epigenetic regulation of the nuclear cccDNA minichromosome. J Clin Invest 122(2):529-537.
19. Pileri P, et al. (1998) Binding of hepatitis C virus to CD81. Science 282(5390):938-941.
20. Scarselli E, et al. (2002) The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus. EMBO J 21(19):5017-5025.
21. Evans MJ, et al. (2007) Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry.Nature 446(7137):801-805.
22. Ploss A, et al. (2009) Human occludin is a hepatitis C virus entry factor required for infection of mouse cells.Nature 457(7231):882-886.
23. Dorner M, et al. (2013) Completion of the entire hepatitis C virus life cycle in genetically humanized mice.Nature 501(7466):237-241.
24. Chang KS, Jiang J, Cai Z, Luo G (2007) Human apolipoprotein e is required for infectivity and production of hepatitis C virus in cell culture. J Virol 81(24):13783-13793.
25. Schlütter J (2011) Therapeutics:New drugs hit the target.Nature 474(7350):S5-S7.
26. Potthoff A, Manns MP, Wedemeyer H (2010) Treatment of HBV/HCV coinfection. Expert Opin Pharmacother 11(6):919-928.
27. Bellecave P, et al. (2009) Hepatitis B and C virus coinfection: A novel model system reveals the absence of direct viral interference. Hepatology 50(1):46-55.
28. Lee YM, Tscherne DM,Yun SI, Frolov I, Rice CM (2005) Dual mechanisms of pestiviral superinfection exclusion at entry and RNA replication. J Virol 79(6):3231-3242.
29. Zhu H, et al. (2009) Primary human hepatocyte culture for HCV study. Methods Mol Biol 510:373-382.
30. Yang D, et al. (2011) Innate host response in primary human hepatocytes with hepatitis C virus infection. PLoS ONE 6(11):e27552.
31. Wong DK, et al. (2011) Occult hepatitis B infection and HBV replicative activity in patients with cryptogenic cause of hepatocellular carcinoma. Hepatology 54(3):829-836.
32. Sambrook J, Fritsh EF, Maniatis T (1989) Molecular Cloning: A Laboratory Manual (Cold Spring Harbor Lab Press,Y).
33. Zhu H, et al. (2003) Gene expression associated with interferon alfa antiviral activity in an HCV replicon cell line. Hepatology 37(5):1180-1188.